FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097848 [Registered on: 21/11/2025] Trial Registered Prospectively
Last Modified On: 19/11/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Case Control Study 
Study Design  Other 
Public Title of Study   A European study to evaluate how doctors care for patients who get a heart ultrasound (called a transthoracic echocardiogram) before having surgery that doesn’t involve the heart, and what happens to those patients during that time. 
Scientific Title of Study   EuPreCHO: European study on perioperative management and outcome following Preoperative Transthoracic Echocardiography in noncardiac surgery patients. 
Trial Acronym  EuPreCHO 
Secondary IDs if Any  
Secondary ID  Identifier 
4980_Version 1.0 dated 04.09.2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Atul Kulkarni 
Designation  Professor and Head, Division of Critical Care Medicine 
Affiliation  Tata Memorial Hospital 
Address  Department of Anaesthesiology, Critical Care & Pain, Major OT Complex, 2nd floor Main Building Tata Memorial Hospital Parel

Mumbai
MAHARASHTRA
400012
India 
Phone  9869077526  
Fax    
Email  kaivalyaak@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Atul Kulkarni 
Designation  Professor and Head, Division of Critical Care Medicine 
Affiliation  Tata Memorial Hospital 
Address  Department of Anaesthesiology, Critical Care & Pain, Major OT Complex, 2nd floor Main Building Tata Memorial Hospital Parel

Mumbai
MAHARASHTRA
400012
India 
Phone  9869077526  
Fax    
Email  kaivalyaak@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Atul Kulkarni 
Designation  Professor and Head, Division of Critical Care Medicine 
Affiliation  Tata Memorial Hospital 
Address  Department of Anaesthesiology, Critical Care & Pain, Major OT Complex, 2nd floor Main Building Tata Memorial Hospital Parel

Mumbai
MAHARASHTRA
400012
India 
Phone  9869077526  
Fax    
Email  kaivalyaak@yahoo.co.in  
 
Source of Monetary or Material Support  
Tata Memorial Hospital Dr E Borges Road Parel Mumbai 400012  
 
Primary Sponsor  
Name  European Society of Anaesthesiology and Intensive Care (ESAIC) 
Address  Rue des Comédiens 24, 1000 Brussels, Belgium 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     Belgium
Germany
India
Sweden  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Atul Kulkarni  Tata Memorial Centre  Department of Anesthesia Critical care and Pain, Second floor, Major OT complex, Main Building, Tata Memorial Centre Dr E Borges Road Parel
Mumbai
MAHARASHTRA 
9869077526

kaivalyaak@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Tata Memorial Hospital Institutional Ethics Committee-2  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1. Patients planned to undergo elective, in-hospital intermediate or high-risk noncardiac surgery
procedures
2. aged more than or equal to 65 years OR
3. presenting more than or equal to 2 cardiovascular risk factors (hypertension, smoking, dyslipidaemia, diabetes,
family history of CVD) OR
4. with known cardiovascular disease  
 
ExclusionCriteria 
Details  1. under 18 years of age
2. day surgery
3. urgent or emergency procedures
4. current ICU patient (i.e. in ICU on day-1 or the day of the index surgery (day 0)),
5. cardiac surgery within the last month prior to the index noncardiac procedure (of note this does not include cardiological interventions like TAVI or valvuloplasty),
6. unwilling or unable to provide informed consent,
7. unable to complete the WHODAS questionnaire (literacy or language barrier)
8. Previous enrollment in EuPreCHO (in case of repeated surgery). 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Difference in current clinical practice with respect to the perioperative management of patients evaluated with vs those not evaluated with
preoperative TTE  
on Post operative day 30 
 
Secondary Outcome  
Outcome  TimePoints 
Difference in current clinical practice with respect to the outcome of patients evaluated with vs those not evaluated with preoperative TTE  on Post operative day 30 
Factors (model) which enhance the prediction of major pathologies in preoperative TTE  on Post operative day 30 
 
Target Sample Size   Total Sample Size="8089"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   08/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  08/12/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

According to current guidelines [1], a relevant proportion of European patients planned for intermediate or high-risk noncardiac surgery procedure are supposed to undergo preoperative TTE. The risk-benefit balance of this approach is unknown and may result in delayed surgery from limited TTE availability and the inherent burdening of institutions without known clinical benefits. Further, European anaesthesiologists are currently confronted with a guideline that they may not be willing to implement due to knowledge gaps or not be able to implement due to logistical barriers. Therefore, before considering reorganizing preoperative TTE logistics is an urgent need to generate knowledge on the outcome impact of TTE prior to noncardiac surgery and to establish criteria that may result in a more targeted use of preoperative TTE. 

 
Close